In the last trading session, 2.55 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.04. Most recently the company’s
During the last session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 3.69 million, with the beta value of the company hitting 2.15. At the end
During the recent session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 1.57 million, with the beta value of the company hitting 2.15. At the last
In the last trading session, 1.97 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.13. Most recently the company’s
In the last trading session, 2.39 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.17. Most recently the company’s
In the last trading session, 5.36 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.18. With the company’s per share
In the last trading session, 7.38 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.18. With the company’s per share
Conduit Pharmaceuticals Inc (NASDAQ:CDT) has a beta value of 2.19 and has seen 13.81 million shares traded in the last trading session. The company, currently
Conduit Pharmaceuticals Inc (NASDAQ:CDT) has a beta value of 2.24 and has seen 56.44 million shares traded in the last trading session. The company, currently
During the last session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 336.97 million, with the beta value of the company hitting 2.25. The 52-week high
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
